Rapid simultaneous determination of indacaterol maleate and glycopyrronium bromide in inhaler capsules using a validated stability-indicating monolithic LC method

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide. A combination of indacaterol maleate with glycopyrronium bromide has recently been approved as a once-daily maintenance therapy in patients with COPD. The very low dose (μg level/capsule)...

Descripción completa

Detalles Bibliográficos
Autores principales: Zayed, Sahar, Belal, Fathalla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418180/
https://www.ncbi.nlm.nih.gov/pubmed/29086816
http://dx.doi.org/10.1186/s13065-017-0264-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418180/
https://www.ncbi.nlm.nih.gov/pubmed/29086816
http://dx.doi.org/10.1186/s13065-017-0264-6

Ejemplares similares